|
Centre for Policy on Ageing | |
 | |
|
The social consequences for families with Alzheimer's disease patients potential impact of new drug treatment | Author(s) | Anders Wimo, Bengt Winblad, Margareta Grafstrom |
Journal title | International Journal of Geriatric Psychiatry, vol 14, no 5, May 1999 |
Pages | pp 338-347 |
Keywords | Dementia ; Family care ; Drugs ; Social surveys ; Sweden ; Netherlands ; United Kingdom. |
Annotation | The social consequences of Alzheimer's disease (AD) are highlighted in this review with regard to impact on family situation, a changing treatment context caused by demographic changes, reorganisation of long-term care, a financial crisis in the public health systems, and the introduction of anti-dementia drugs. In the early phase of dementia, there may be significant consequences for the patients and family members which are largely unrecognised by the healthcare system. As the disease progresses, the impact on caregivers in terms of physical and emotional burden, financial and employment status may be enormous. The current care provision in Sweden, the Netherlands and the UK is described. Innovative care alternatives and strategies may improve the situation. The introduction of anti-dementia drugs such as the acetylcholinesterase inhibitors may also contribute to improved circumstances for patients and caregivers. There is still a great need for further research in this field. (RH). |
Accession Number | CPA-990825256 A |
Classmark | EA: P6:SJ: LLD: 3F: 76P: 76H: 8 |
Data © Centre for Policy on Ageing |
|
...from the Ageinfo database published by Centre for Policy on Ageing. |
| |
|